EEF2K and neoplasm: In addition, the ability to penetrate tumors and tumor cell–killing functions are impaired in CD8+ T cells deficient in eEF-2K (Fig. 6A), which could be a consequence of premature exhaustion and senescence of these cells (Fig. 1).